If you have been living with an overactive bladder, urge incontinence, or related bladder control challenges and are looking for a non-surgical approach like Botox, understanding how Botox is used to treat these conditions can help you make more informed decisions about your care. With this guide, we will cover everything you need to know about how botulinum toxin is delivered to the bladder wall, who may benefit from treatment, what the procedure involves, and what you can realistically expect from outcomes.
Whether you are exploring this option for the first time or preparing questions for an upcoming consultation, the goal here is to give you a solid foundation of knowledge.
How Botulinum Toxin Works in the Bladder
Botox is a purified form of botulinum toxin, a protein derived from the bacterium Clostridium botulinum. When injected into the detrusor muscle of the bladder wall, the toxin works by inhibiting acetylcholine release at the nerve-muscle junction. Acetylcholine is the chemical messenger responsible for triggering bladder muscle contractions. By interrupting this signal, botulinum toxin reduces the involuntary muscle spasms that cause a sudden and urgent need to urinate.
That said, the mechanism is temporary. Over time, nerve endings regenerate, and the signalling pathway gradually resumes, which is why repeat treatments are typically needed to maintain the effect. The botulinum neurotoxin does not destroy nerve tissue permanently; it simply creates a window of reduced neuromuscular activity that allows the bladder to behave more predictably.
This approach differs from oral medications, which work systemically and can cause side effects throughout the body. These intradetrusor injections deliver the toxin directly to the target tissue, allowing for a more localized response with a different side effect profile.
Conditions Treated with Bladder Botox Injections
Bladder Botox injections are most commonly used for two primary indications: neurogenic detrusor overactivity and idiopathic detrusor overactivity. Understanding the distinction between these two concerns can help clarify who is most likely to be considered a candidate.
Neurogenic Detrusor Overactivity
Neurogenic detrusor overactivity occurs when an underlying neurological condition disrupts normal bladder control. Conditions such as multiple sclerosis, spinal cord injury, and other neurological disorders can impair the nerve signals that regulate when and how strongly the bladder contracts. Patients with these conditions often experience urge incontinence, frequent urgency, and difficulty managing urine flow. Botulinum toxin injections into the bladder wall have a well-established effectiveness for this type of overactivity.
Idiopathic Detrusor Overactivity and Overactive Bladder
Idiopathic detrusor overactivity refers to overactive bladder symptoms without an identified neurological cause. Many patients in this category have tried behavioral therapies, pelvic floor physiotherapy, and oral medications with limited success. For this group, Botox injections may be considered after other treatments have not provided adequate relief. Interstitial cystitis and other chronic bladder conditions may also be discussed in the context of botulinum toxin therapy, though the approach may differ.
Patients with urge incontinence, the involuntary leakage that accompanies a sudden, strong urge to urinate, are among those who may experience the most meaningful symptom reduction with this treatment.
Understanding the Bladder Botox Injection Technique
The bladder Botox injection technique involves delivering measured amounts of botulinum toxin type A directly into the detrusor muscle through a minimally invasive endoscopic procedure. The process uses a cystoscope, a thin, lighted instrument inserted through the urethra, to provide a clear view of the interior bladder wall. Most commonly, a flexible cystoscope is used in an office setting, though in some cases, rigid cystoscopes may be preferred depending on the circumstances.
How the Injections Are Delivered
Once the cystoscope is in position, a thin injection needle is passed through the working channel of the instrument. The physician then delivers the toxin at multiple sites across the bladder wall using a systematic approach designed to achieve even distribution throughout the detrusor muscle. The injection needle is advanced through the mucosal lining into the muscle layer beneath, and a small volume of the toxin is deposited at each site.
The injections are typically placed across the posterior and lateral walls of the bladder. Most injection techniques avoid the bladder dome and the area immediately surrounding the urethra to minimize the risk of urinary retention and other complications.
Anesthesia Options and Office Setting
One of the practical advantages of bladder Botox treatment is that it can often be performed in an office setting, which reduces the logistical burden for patients when compared to procedures requiring hospital admission.
Local Anesthesia
Most patients who undergo this procedure in an outpatient context receive local anesthesia administered directly into the bladder. Lidocaine solution is instilled into the bladder through the cystoscope or a catheter prior to the injections. The lidocaine is allowed to dwell for a period of time to numb the bladder lining before the procedure begins. This approach makes the procedure more comfortable for most patients while avoiding the risks and recovery time associated with deeper anesthesia methods.
Local anesthesia with lidocaine is also generally well-tolerated by most patients. Some individuals may experience mild pressure or urgency during the procedure, which typically resolves once it is complete. Your provider will discuss comfort measures available during the consultation process.
General Anesthesia
In some cases, general anesthesia may be recommended. This is more common when the procedure is being performed for neurogenic detrusor overactivity related to a spinal cord injury or other complex neurological conditions, or when patient anatomy or comfort makes an office-based approach less suitable. The decision between local anesthesia and general anesthesia is made based on the individual patient’s clinical needs and preferences.
Dose, Number of Injections, and Injection Sites on the Bladder Wall
The dose of botulinum toxin administered during a bladder treatment session varies depending on what is being treated.
Approved Dosing Ranges
For non-neurogenic overactive bladder with urge incontinence, the approved dose in many guidelines is 100 units of Botox, injected across approximately 20 sites in the bladder wall. For neurogenic detrusor overactivity, a higher dose of 200 units is typically used and administered across a similar number of injection sites. These doses have been established through clinical trials.
The dose delivered at each site is small, and the total volume injected into the bladder is carefully calculated to minimize the risk of systemic spread.
Injection Site Distribution Across the Bladder Wall
Sites are distributed across the posterior wall and lateral walls of the bladder in a grid-like pattern. Spacing between injection points is important to achieve broad coverage of the detrusor muscle without concentrating the toxin in one area. The bladder dome is typically avoided to reduce the risk of affecting structures near the ureteral openings. Dr. Lazare will explain the specific approach used in your case during your consultation.
Risks, Side Effects, and Breathing Difficulties
As with any medical procedure, bladder Botox injections carry potential risks and side effects. Understanding these helps patients make an informed decision in partnership with their physician.
Urinary Retention
One of the most clinically relevant risks associated with intradetrusor injection is urinary retention or difficulty emptying the bladder fully or completely. Urinary retention can occur when the botulinum toxin has a stronger-than-expected effect on the detrusor muscle, reducing its ability to contract effectively during urination. Most patients who experience retention find it is temporary, resolving as the toxin effect diminishes over the months following treatment.
Urinary Tract Infections
Urinary tract infections can occur following bladder Botox injections, as the procedure involves introducing instruments through the urethra. Prophylactic antibiotics are typically administered to reduce this risk. Patients are advised to monitor for symptoms such as burning with urination, increased frequency, cloudy urine, or fever following the procedure and to contact their provider if these occur.
Other Potential Side Effects
Other side effects that may occur include temporary discomfort at the injection sites, mild haematuria (blood in the urine) in the days following the procedure, and transient urgency symptoms. Most patients tolerate the recovery period without significant disruption to daily activities, though individual recovery varies.
Results and Duration
Many patients who have Botox treatment experience meaningful improvement in overactive bladder symptoms, including a reduction in urge incontinence episodes, decreased urinary frequency, and improved ability to hold urine.
The results typically begin to emerge within one to two weeks of the injections, with most patients noticing noticeable improvement by the third or fourth week. The duration of effect varies by individual patient, but many patients find that results are maintained for approximately six to twelve months before symptoms begin to return. At that point, repeat treatment can be considered.
In some cases, behavioral strategies, pelvic floor physiotherapy, or adjunctive medications may be discussed alongside Botox therapy to support the best possible outcomes. Dr. Lazare will help set realistic expectations based on your specific clinical profile.
Why Choose Darren Lazare, MD in Vancouver
When considering a procedure like bladder Botox injections, the experience and training of your physician matter. Dr. Darren Lazare is a board-certified gynecologist with subspecialty fellowship training in female pelvic medicine and reconstructive surgery, completed at the University of Alberta. His residency training was completed at the University of British Columbia, and he currently holds an appointment as a Clinical Associate Professor at UBC, where he serves as residency supervisor for the urogynecology program.
Dr. Lazare brings extensive experience in the full range of conditions affecting bladder function and pelvic health in women. His practice encompasses both reconstructive and cosmetic procedures, grounded in a commitment to women’s health and evidence-based care. He is a Surgeon Champion for the American College of Surgeons’ National Surgical Quality Improvement Program (NSQIP), reflecting a commitment to quality outcomes and patient safety.
Dr. Lazare’s practice serves patients in Vancouver, British Columbia, as well as those travelling from Burnaby, Richmond, Surrey, and across the Lower Mainland. His approach prioritizes giving each individual patient the time and information they need to make confident, well-informed decisions about their care.
Ready to discuss whether bladder Botox treatment may be appropriate for your situation? Contact Dr. Darren Lazare’s office to schedule a consultation, or call (604) 806-6365 to speak with the team directly.
Frequently Asked Questions About Bladder Botox Injections
How do I know if I am a good candidate for bladder Botox treatment?
Candidacy is determined through a comprehensive evaluation that considers your symptoms, medical history, prior treatments, and overall health. Bladder Botox is generally considered after behavioral strategies and oral medications have not provided adequate relief for overactive bladder or urge incontinence. A consultation with Dr. Lazare is the appropriate starting point to assess whether this treatment suits your individual situation.
How many treatment sessions will I need over time?
Because the effect of botulinum toxin is temporary, most patients require repeat injections as symptoms return, typically every six to twelve months, though this varies by individual patient. We will monitor your response and help you plan a treatment schedule that aligns with your symptom patterns and lifestyle.
What is the difference between bladder Botox and oral medications for an overactive bladder?
Oral medications for overactive bladder work throughout the nervous system and can cause systemic side effects such as dry mouth, constipation, and blurred vision. Bladder Botox delivers the toxin directly to the bladder wall, allowing for a more localized effect. Many patients who have not tolerated or responded adequately to medications find that intradetrusor injection provides more significant results.
Is the cost of bladder Botox injections covered by provincial health insurance in British Columbia?
Coverage for bladder Botox procedures may vary depending on your specific diagnosis, clinical history, and provincial health plan criteria. Some patients may qualify for coverage while others may not. It is best to discuss the financial aspects of your treatment plan directly during your consultation, as coverage determinations depend on individual circumstances.
How long does the injection procedure itself take?
The procedure is typically completed within fifteen to thirty minutes in most cases, though preparation and monitoring time will extend your overall appointment. Recovery observation following the procedure is standard, and most patients are able to return home the same day. The duration can vary based on individual anatomy, the anesthesia approach used, and clinical factors specific to each patient.
Can bladder Botox be combined with other treatments for pelvic floor conditions?
In many cases, bladder Botox is part of a broader, individualized approach to managing bladder and pelvic floor health. Pelvic floor physiotherapy, behavioral bladder training, and other interventions may complement the effects of botulinum toxin treatment.
What should I do if my symptoms return before my next scheduled appointment?
If you notice your overactive bladder or urge incontinence symptoms returning before your anticipated follow-up, contact us to discuss the timing of retreatment. The return of symptoms does not necessarily mean the treatment was unsuccessful. It may simply indicate that the duration for your individual response has been reached. Retreatment is routinely offered when clinically appropriate.
Schedule a Consultation
Now that you have a thorough understanding of the bladder Botox injection technique, including how botulinum toxin works in the bladder wall, what the procedure involves, and what patients may realistically expect, the next step is a personalized consultation to explore whether this treatment is appropriate for your individual circumstances. Dr. Darren Lazare welcomes patients from across Vancouver, British Columbia, and the surrounding region who are looking for experienced, compassionate care for overactive bladder and urinary incontinence. To schedule your consultation, visit our contact page or call us at (604) 806-6365 today.
Dr. Darren Lazare
Restorative Gynecology Surgeon | BLOG
Dr. Darren Lazare received his residency training in Obstetrics and Gynaecology at the University of British Columbia. He successfully completed his subspecialty fellowship training in female pelvic medicine and reconstructive surgery at the University of Alberta. Dr. Lazare has been appointed as a Clinical Associate Professor at the University of British Columbia where he is the residency supervisor for the urogynecology program. He is a Surgeon Champion for the American College of Surgeon’s National Surgical Quality Improvement Program (NSQIP). He is a committed advocate for women’s health, medical education and quality improvement initiatives while maintaining a full clinical, reconstructive and cosmetic practice. Dr. Lazare’s professional memberships include the Royal College of Physicians and Surgeons, the Canadian Society of Pelvic Medicine, the International Urogynecology Association, the International Continence Society and the American Urogynecology Society.